Evaluation of genetic risk score models in the presence of interaction and linkage disequilibrium

Frontiers in Genetics

Volumn 4, Issue JUL, 2013, Pages

  Che, Ronglin ^a   Motsinger Reif, Alison A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Explained variance; Genetic risk score (GRS); Interaction; Linkage disequilibrium (LD); Predictive modeling

Indexed keywords

EID: 84883516408     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00138     Document Type: Article

References (22)

1. Carayol, J., Tores, F., Konig, I. R., Hager, J., and Ziegler, A. (2010). Evaluating diagnostic accuracy of genetic profiles in affected offspring families. Stat. Med. 29, 2359-2368. doi: 10.1002/sim.4006
2. Che, R., and Motsinger-Reif, A. A. (2012). A new explained-variance based genetic risk score for predictive modeling of disease risk. Stat. Appl. Genet. Mol. Biol. 11:15. doi: 10.1515/1544-6115.1796
3. Che, R., Motsinger-Reif, A. A., and Brown, C. C. (2012). Loss of power in two-stage residual-outcome regression analysis in genetic association studies. Genet. Epidemiol. 36, 890-894. doi: 10.1002/gepi.21671
4. Cordell, H. J. (2002). Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum. Mol. Genet. 11, 2463-2468. doi: 10.1093/hmg/11.20.2463
5. Cordell, H. J. (2009). Detecting gene-gene interactions that underlie human diseases. Nat. Rev. Genet. 10, 392-404. doi: 10.1038/nrg2579
6. Culverhouse, R., Suarez, B. K., Lin, J., and Reich, T. (2002). A perspective on epistasis: limits of models displaying no main effect. Am. J. Hum. Genet. 70, 461-471. doi: 10.1086/338759
7. Hess, K. R., Anderson, K., Symmans, W. F., Valero, V., Ibrahim, N., Mejia, J. A., et al. (2006). Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J. Clin. Oncol. 24, 4236-4244. doi: 10.1200/JCO.2006.05.6861
8. Hu, T., Sinnott-Armstrong, N. A., Kiralis, J. W., Andrew, A. S., Karagas, M. R., and Moore, J. H. (2011). Characterizing genetic interactions in human disease association studies using statistical epistasis networks. BMC Bioinformatics 12:364. doi: 10.1186/1471-2105-12-364
9. Klein, T. E., Altman, R. B., Eriksson, N., Gage, B. F., Kimmel, S. E., Lee, M. T., et al. (2009). Estimation of the warfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med. 360, 753-764. doi: 10.1056/NEJMoa0809329
10. Lunetta, K. L. (2008). Genetic association studies. Circulation 118, 96-101. doi: 10.1161/CIRCULATIONAHA.107.700401
11. Manolio, T. A. (2010). Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med. 363, 166-176. doi: 10.1056/NEJMra0905980
12. McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P., et al. (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9, 356-369. doi: 10.1038/nrg2344
13. Meigs, J. B., Shrader, P., Sullivan, L. M., McAteer, J. B., Fox, C. S., Dupuis, J., et al. (2008). Genotype score in addition to common risk factors for prediction of type 2 diabetes. N. Engl. J. Med. 359, 2208-2219. doi: 10.1056/NEJMoa0804742
14. Park, J. H., Wacholder, S., Gail, M. H., Peters, U., Jacobs, K. B., Chanock, S. J., et al. (2010). Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet. 42, 570-575. doi: 10.1038/ng.610
15. Pattin, K. A., White, B. C., Barney, N., Gui, J., Nelson, H. H., Kelsey, K. T., et al. (2009). A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet. Epidemiol. 33, 87-94. doi: 10.1002/gepi.20360
16. Paynter, N. P., Chasman, D. I., Pare, G., Buring, J. E., Cook, N. R., Miletich, J. P., et al. (2010). Association between a literature-based genetic risk score and cardiovascular events in women. JAMA 303, 631-637. doi: 10.1001/jama.2010.119
17. Ritchie, M. D. (2012). The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Hum. Genet. 131, 1615-1626. doi: 10.1007/s00439-012-1221-z
18. Shifman, S., Kuypers, J., Kokoris, M., Yakir, B., and Darvasi, A. (2003). Linkage disequilibrium patterns of the human genome across populations. Hum. Mol. Genet. 12, 771-776. doi: 10.1093/hmg/ddg088
19. Talmud, P. J., Hingorani, A. D., Cooper, J. A., Marmot, M. G., Brunner, E. J., Kumari, M., et al. (2010). Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: whitehall II prospective cohort study. BMJ 340:b4838. doi: 10.1136/bmj.b4838
20. Visscher, P. M., Hill, W. G., and Wray, N. R. (2008). Heritability in the genomics era-concepts and misconceptions. Nat. Rev. Genet. 9, 255-266. doi: 10.1038/nrg2322
21. Winham, S. J., Colby, C. L., Freimuth, R. R., Wang, X., de Andrade, M., Huebner, M., et al. (2012). SNP interaction detection with Random Forests in highdimensional genetic data. BMC Bioinformatics 13:164. doi: 10.1186/1471-2105-13-164
22. Winham, S. J., Slater, A. J., and Motsinger-Reif, A. A. (2010). A comparison of internal validation techniques for multifactor dimensionality reduction. BMC Bioinformatics 11:394. doi: 10.1186/1471-2105-11-394